The unprecedented public health and economic impact of the COVID-19 pandemic caused
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has undergone
multiple mutations since its emergence, and its latest variant, Omicron (B. 1.1. 529), is the …

Abstract Vaccine‐induced SARS‐CoV‐2 antibody responses are attenuated in solid organ
transplant recipients (SOTRs) and breakthrough infections are more common. Additional …

Herd immunity achieved through mass vaccination is an effective approach to prevent
contagious diseases. Nonetheless, emerging SARS-CoV-2 variants with frequent mutations …

The impact of vaccination on SARS-CoV-2 infectiousness is not well understood. We
compared longitudinal viral shedding dynamics in unvaccinated and fully vaccinated adults …

Associations between vaccine breakthrough cases and infection by different SARS
coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analysed …

Covid-19: How many variants are there, and what do we know about them? | The BMJ Skip to
main content Intended for healthcare professionals Access provided by Google Indexer …

Background Currently, promoted vaccinations against SARS-CoV-2 are being given out
globally. However, the occurrence of numerous COVID-19 variants has hindered the goal of …

Background SARS-CoV-2 vaccines are highly effective at preventing COVID-19-related
morbidity and mortality. As no vaccine is 100% effective, breakthrough infections are …

SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which
effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of the host cell …